Yabo Zhou

3.5k total citations · 3 hit papers
39 papers, 1.7k citations indexed

About

Yabo Zhou is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Yabo Zhou has authored 39 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 14 papers in Oncology and 12 papers in Immunology. Recurrent topics in Yabo Zhou's work include CAR-T cell therapy research (6 papers), Immune Cell Function and Interaction (5 papers) and Cellular Mechanics and Interactions (4 papers). Yabo Zhou is often cited by papers focused on CAR-T cell therapy research (6 papers), Immune Cell Function and Interaction (5 papers) and Cellular Mechanics and Interactions (4 papers). Yabo Zhou collaborates with scholars based in China, United States and Sweden. Yabo Zhou's co-authors include Jiadi Lv, Yuying Liu, Ke Tang, Feiran Cheng, Jing Xie, Bo Huang, Jingwei Ma, Tianzhen Zhang, Xiaoyu Liang and Nannan Zhou and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Yabo Zhou

35 papers receiving 1.7k citations

Hit Papers

Gasdermin E–mediated target cell pyroptosis by CAR T cell... 2018 2026 2020 2023 2020 2018 2024 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yabo Zhou China 19 793 615 469 222 180 39 1.7k
Jiadi Lv China 22 1.2k 1.5× 797 1.3× 491 1.0× 325 1.5× 227 1.3× 37 2.3k
Zhiying Yang China 23 533 0.7× 277 0.5× 502 1.1× 142 0.6× 256 1.4× 104 1.9k
Simi Ali United Kingdom 30 707 0.9× 828 1.3× 765 1.6× 130 0.6× 144 0.8× 105 2.4k
Venkataswarup Tiriveedhi United States 29 655 0.8× 528 0.9× 341 0.7× 137 0.6× 197 1.1× 76 2.1k
Yongjie Zhou China 26 870 1.1× 563 0.9× 563 1.2× 187 0.8× 183 1.0× 100 2.3k
Xingbin Hu China 20 1.2k 1.5× 607 1.0× 393 0.8× 135 0.6× 267 1.5× 65 2.4k
Breanna M. Allen United States 8 660 0.8× 624 1.0× 702 1.5× 194 0.9× 116 0.6× 10 1.8k
Conor J. Kearney Australia 20 1.1k 1.3× 978 1.6× 598 1.3× 92 0.4× 194 1.1× 30 1.9k
Xiaoyu Zhang China 23 730 0.9× 1.1k 1.8× 397 0.8× 86 0.4× 218 1.2× 83 2.3k

Countries citing papers authored by Yabo Zhou

Since Specialization
Citations

This map shows the geographic impact of Yabo Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yabo Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yabo Zhou more than expected).

Fields of papers citing papers by Yabo Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yabo Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yabo Zhou. The network helps show where Yabo Zhou may publish in the future.

Co-authorship network of co-authors of Yabo Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Yabo Zhou. A scholar is included among the top collaborators of Yabo Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yabo Zhou. Yabo Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Zhou, Li, Dongxiao Wu, Yabo Zhou, et al.. (2025). Heterozygous human JAK2V617F activates AhR to drive essential thrombocythemia and promote thrombosis. The Journal of Experimental Medicine. 222(12).
3.
Zhou, Yabo, Xia Li, Menghan Chen, et al.. (2025). The synergistic administration of sanguinarine and curcumin ameliorates indomethacin-induced small intestinal injury in rats through the modulation of Nrf2 and NF-κB signaling pathways. Biochemical and Biophysical Research Communications. 781. 152551–152551.
4.
Zhou, Yabo, Chaoying Zhang, Yan Kang, et al.. (2025). Glucose-1-phosphate promotes compartmentalization of glycogen with the pentose phosphate pathway in CD8+ memory T cells. Molecular Cell. 85(13). 2535–2549.e10. 2 indexed citations
5.
Lv, Jiadi, Dianheng Wang, Yabo Zhou, et al.. (2025). Mechanical signaling via β2 integrin decouples T cell proliferation and differentiation for generating stem cell-like CAR T cells. Immunity. 58(9). 2289–2304.e10. 2 indexed citations
6.
Zhang, Yongliang, et al.. (2024). Feasibility of natural bamboo branches aggregate applied to the thermal insulation layer of rock walls in roadways. Construction and Building Materials. 435. 136870–136870. 2 indexed citations
7.
Chen, Jie, Yabo Zhou, Kexin Cao, et al.. (2024). Hepatic glycogenesis antagonizes lipogenesis by blocking S1P via UDPG. Science. 383(6684). eadi3332–eadi3332. 28 indexed citations
8.
Zhou, Yabo, Dianheng Wang, Li Zhou, et al.. (2024). Cell softness renders cytotoxic T lymphocytes and T leukemic cells resistant to perforin-mediated killing. Nature Communications. 15(1). 1405–1405. 19 indexed citations
10.
Zhou, Li, Dongxiao Wu, Yabo Zhou, et al.. (2023). Tumor cell-released kynurenine biases MEP differentiation into megakaryocytes in individuals with cancer by activating AhR–RUNX1. Nature Immunology. 24(12). 2042–2052. 20 indexed citations
11.
Zhou, Nannan, Jie Chen, Ling Zheng, et al.. (2023). Aryl hydrocarbon receptor sulfenylation promotes glycogenolysis and rescues cancer chemoresistance. Journal of Clinical Investigation. 133(24). 19 indexed citations
12.
Zhang, Huafeng, Jincheng Liu, Zhuoshun Yang, et al.. (2022). TCR activation directly stimulates PYGB-dependent glycogenolysis to fuel the early recall response in CD8+ memory T cells. Molecular Cell. 82(16). 3077–3088.e6. 29 indexed citations
13.
Lv, Jiadi, Yuying Liu, Yabo Zhou, et al.. (2022). Gasdermin E mediates resistance of pancreatic adenocarcinoma to enzymatic digestion through a YBX1–mucin pathway. Nature Cell Biology. 24(3). 364–372. 43 indexed citations
14.
Wang, Zhenfeng, Jiadi Lv, Pin Yü, et al.. (2022). SARS-CoV-2 treatment effects induced by ACE2-expressing microparticles are explained by the oxidized cholesterol-increased endosomal pH of alveolar macrophages. Cellular and Molecular Immunology. 19(2). 210–221. 24 indexed citations
15.
Tang, Ke, Liyan Zhu, Jie Chen, et al.. (2021). Hypoxia Promotes Breast Cancer Cell Growth by Activating a Glycogen Metabolic Program. Cancer Research. 81(19). 4949–4963. 75 indexed citations
16.
Liu, Yuying, Tianzhen Zhang, Haizeng Zhang, et al.. (2020). Cell Softness Prevents Cytolytic T-cell Killing of Tumor-Repopulating Cells. Cancer Research. 81(2). 476–488. 88 indexed citations
17.
Liu, Yuying, Jiadi Lv, Jiangning Liu, et al.. (2020). Mucus production stimulated by IFN-AhR signaling triggers hypoxia of COVID-19. Cell Research. 30(12). 1078–1087. 92 indexed citations
18.
Liu, Yuying, Jiadi Lv, Xiaoyu Liang, et al.. (2018). Fibrin Stiffness Mediates Dormancy of Tumor-Repopulating Cells via a Cdc42-Driven Tet2 Epigenetic Program. Cancer Research. 78(14). 3926–3937. 88 indexed citations
19.
Chen, Degao, Jing Xie, Roland Fiskesund, et al.. (2018). Chloroquine modulates antitumor immune response by resetting tumor-associated macrophages toward M1 phenotype. Nature Communications. 9(1). 873–873. 389 indexed citations breakdown →
20.
Bissonnette, Robert, Yves Poulin, Yabo Zhou, et al.. (2011). Efficacy and safety of topical WBI-1001 in patients with mild to severe atopic dermatitis: results from a 12-week, multicentre, randomized, placebo-controlled double-blind trial. British Journal of Dermatology. 166(4). 853–860. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026